Showing results (121-130 of 167) with videos related to

Sort By:
Pageof 17
The Biochemical Journal|July 20, 2005
Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitorsDouglas R Hurst, Martin A Schwartz, Yonghao Jin, et al.
The American Journal of Dermatopathology|June 17, 2006
Angiotropism of human melanoma: studies involving in transit and other cutaneous metastases and the chicken chorioallantoic membrane: implications for extravascular melanoma invasion and metastasisClaire Lugassy, Stephen E Vernon, Klaus Busam, et al.
Molecular Oncology|June 26, 2023
Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapyLanjing Wei, Qi Zhang, Cuncong Zhong, et al.
Experimental Cell Research|February 2, 2002
Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1Lalita A Shevde, Rajeev S Samant, Steven F Goldberg, et al.
Cancer Research|November 25, 2010
Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibitionThomas M Bodenstine, Kedar S Vaidya, Aimen Ismail, et al.
The Journal of Biological Chemistry|October 9, 2003
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modelingHyun I Park, Yonghao Jin, Douglas R Hurst, et al.
The Biochemical Journal|October 10, 2003
Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activitiesDouglas R Hurst, Martin A Schwartz, Mohammad A Ghaffari, et al.
Cancer Immunology Research|February 5, 2015
SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor CellsHao Yu, Yudong Liu, Braden C McFarland, et al.
Journal of Cellular Biochemistry|January 27, 2004
Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradationAndrea M Mastro, Carol V Gay, Danny R Welch, et al.
Clinical & Experimental Metastasis|July 11, 2006
Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435Lalita A Shevde, Rajeev S Samant, Jason C Paik, et al.
Pageof 17